A combination of common and minor variations in five regions of DNA can help predict a man’s risk of getting prostate cancer, researchers reported Wednesday.
According to today's New York Times:
"A company formed by researchers at Wake Forest University School of Medicine is expected to make the test available in a few months, said Karen Richardson, a Wake Forest spokeswoman. It should cost less than $300.
This is, some medical experts say, a first taste of what is expected to be a revolution in medical prognostication. The results, they agree, are clear. But the question is what happens next."
Here’s a link to the complete story:
http://www.nytimes.com/2008/01/17/health/17cancer.html?scp=1&sq=medical+test
According to today's New York Times:
"A company formed by researchers at Wake Forest University School of Medicine is expected to make the test available in a few months, said Karen Richardson, a Wake Forest spokeswoman. It should cost less than $300.
This is, some medical experts say, a first taste of what is expected to be a revolution in medical prognostication. The results, they agree, are clear. But the question is what happens next."
Here’s a link to the complete story:
http://www.nytimes.com/2008/01/17/health/17cancer.html?scp=1&sq=medical+test
